Enovis (ENOV) Other Accumulated Expenses (2010 - 2011)
Enovis' (ENOV) quarterly Other Accumulated Expenses came in at $80.4 million in Q4 2011, up 75.15% year-over-year from $45.9 million in Q4 2010, and up 26.97% quarter-over-quarter from $63.4 million in Q3 2011.
Powered by 
Analysis
Enovis (ENOV) Other Accumulated Expenses (2010 - 2011) Analysis & Trends
Enovis (ENOV) has reported Other Accumulated Expenses for 2 consecutive years, with $80.4 million the latest figure, recorded in Q4 2011.
- On a quarterly basis, Other Accumulated Expenses rose 75.15% year-over-year to $80.4 million in Q4 2011; TTM through Dec 2011 was $80.4 million, a 75.15% increase from a year earlier, with the FY2011 full-year figure at $80.4 million, up 75.15% from the prior year.
- Other Accumulated Expenses was $80.4 million for Q4 2011 at Enovis, up from $63.4 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $80.4 million in Q4 2011 and troughed at $45.9 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 80.44 Mn |
| Sep 30, 2011 | 63.35 Mn |
| Jul 1, 2011 | 50.03 Mn |
| Dec 31, 2010 | 45.93 Mn |